Black Rock Inc. Annexon, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,043,530 shares of ANNX stock, worth $24.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,043,530

Previous 3,318,579 51.98%

Holding current value

$24.4 Million

Previous $15.1 Million 140.02%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.03 - $7.81 $6.95 Million - $13.5 Million	1,724,951 Added 51.98%	5,043,530 $36.2 Million
Q4 2023 Feb 13, 2024	SELL	$1.63 - $4.63 $145,738 - $413,968	-89,410 Reduced 2.62%	3,318,579 $15.1 Million
Q3 2023 Nov 13, 2023	SELL	$2.13 - $3.84 $153,161 - $276,122	-71,907 Reduced 2.07%	3,407,989 $8.04 Million
Q2 2023 Aug 11, 2023	BUY	$2.1 - $6.37 $4.87 Million - $14.8 Million	2,318,780 Added 199.7%	3,479,896 $12.2 Million
Q1 2023 May 12, 2023	BUY	$3.74 - $7.46 $3,141 - $6,266	840 Added 0.07%	1,161,116 $4.47 Million

Q4 2022 Feb 13, 2023	BUY	$4.56 - $6.02 $90,415 - $119,364	19,828 Added 1.74%	1,160,276 $6 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $6.63 $672,768 - $1.19 Million	179,405 Added 18.67%	1,140,448 $7.05 Million
Q2 2022 Aug 12, 2022	SELL	$2.11 - $4.06 $3.39 Million - $6.53 Million	-1,608,854 Reduced 62.6%	961,043 $3.62 Million
Q1 2022 May 12, 2022	SELL	$2.73 - $11.94 $122,014 - $533,646	-44,694 Reduced 1.71%	2,569,897 $7.02 Million
Q4 2021 Feb 10, 2022	SELL	$11.49 - $22.0 $3.04 Million - $5.81 Million	-264,283 Reduced 9.18%	2,614,591 $30 Million
Q3 2021 Nov 09, 2021	SELL	$16.35 - $23.4 $4.2 Million - $6.01 Million	-256,944 Reduced 8.19%	2,878,874 $53.6 Million
Q2 2021 Aug 11, 2021	BUY	$17.81 - $27.48 $55.8 Million - $86.2 Million	3,135,818 New	3,135,818 $70.6 Million

Others Institutions Holding ANNX

# of Institutions

138

Shares Held

87.3M

Call Options Held

2.54M

Put Options Held

556K

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $230M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account